ID

175

Description

ODM derived from http://clinicaltrials.gov/ct2/show/NCT00220779?term=NCT00220779&rank=1

Link

http://clinicaltrials.gov/ct2/show/NCT00220779?term=NCT00220779&rank=1

Keywords

  1. 2/16/12 2/16/12 -
  2. 4/13/14 4/13/14 - Julian Varghese
Uploaded on

February 16, 2012

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0 Legacy

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility NCT00220779 Multiple sclerosis

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Einschlusskriterien
Alter
Geschlecht
Symptoms consistent with Multiple Sclerosis up to 5 years
Symptome Multiple Sklerose
Diagnose Multiple Sklerose
Kurtzke Extended Disability Status Scale (EDSS) < 5.0
Kontrazeption
Klinisch stabil
Hyperintense Läsionen in den Basalganglien im MRI
Einverständniserklärung
Ausschlusskriterien
Schwanger, stillen oder ohne ausreichende Kontrazeption
Immunsuppression
Steroid Therapie
Interferon, Glatiramer Azetat oder IGIV Therapie
Use of an investigational compound within 6 months prior to study entry
Herzerkrankungen
Niereninsuffizienz
IgA Defizienz
Conditions whose symptoms and effects could alter protein catabolism and/or IgG utilization (e.g., protein-losing enteropathies, nephrotic syndrome)
Medizinische Konzepte

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial